BRPI0810917A2 - Métodos do exame para interação obrigatória usando jogos das micropartículas e de pontas de prova originais - Google Patents

Métodos do exame para interação obrigatória usando jogos das micropartículas e de pontas de prova originais

Info

Publication number
BRPI0810917A2
BRPI0810917A2 BRPI0810917-6A2A BRPI0810917A BRPI0810917A2 BR PI0810917 A2 BRPI0810917 A2 BR PI0810917A2 BR PI0810917 A BRPI0810917 A BR PI0810917A BR PI0810917 A2 BRPI0810917 A2 BR PI0810917A2
Authority
BR
Brazil
Prior art keywords
games
micropartment
compulsory
interaction
original
Prior art date
Application number
BRPI0810917-6A2A
Other languages
English (en)
Portuguese (pt)
Inventor
Jar-How Lee
Thoa Nong
Terrence Chen
Original Assignee
One Lambda Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by One Lambda Inc filed Critical One Lambda Inc
Publication of BRPI0810917A2 publication Critical patent/BRPI0810917A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
BRPI0810917-6A2A 2007-05-03 2008-05-01 Métodos do exame para interação obrigatória usando jogos das micropartículas e de pontas de prova originais BRPI0810917A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91592007P 2007-05-03 2007-05-03
PCT/US2008/062194 WO2008137530A1 (en) 2007-05-03 2008-05-01 Methods of screening for binding interaction using sets of microparticles and unique probes

Publications (1)

Publication Number Publication Date
BRPI0810917A2 true BRPI0810917A2 (pt) 2014-10-29

Family

ID=39943918

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810917-6A2A BRPI0810917A2 (pt) 2007-05-03 2008-05-01 Métodos do exame para interação obrigatória usando jogos das micropartículas e de pontas de prova originais

Country Status (8)

Country Link
US (2) US8748090B2 (enExample)
EP (1) EP2152908B1 (enExample)
JP (2) JP5684564B2 (enExample)
CN (2) CN101802217B (enExample)
AU (1) AU2008247686B2 (enExample)
BR (1) BRPI0810917A2 (enExample)
CA (1) CA2686211C (enExample)
WO (1) WO2008137530A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2389585A2 (en) * 2009-01-22 2011-11-30 Li-Cor, Inc. Single molecule proteomics with dynamic probes
EP3225697A3 (en) 2010-12-30 2017-11-22 Foundation Medicine, Inc. Optimization of multigene analysis of tumor samples
US9547011B2 (en) 2013-03-14 2017-01-17 Tricol Biomedical, Inc. Biocompatible and bioabsorbable derivatized chitosan compositions
US10571468B2 (en) 2014-05-09 2020-02-25 One Lambda, Inc. Modified Fc gamma receptor type III (FCγIII, HNA-1) polypeptides and the uses thereof
ES2989276T3 (es) 2014-12-05 2024-11-25 Found Medicine Inc Análisis multigénico de muestras tumorales
CN105158459A (zh) * 2015-07-10 2015-12-16 南京师范大学 一种水凝胶二氧化硅光子晶体微球化学发光法高灵敏度、低背景检测伏马毒素b1的方法
US20170082619A1 (en) * 2015-09-23 2017-03-23 One Lambda, Inc. Methods of Detecting Alloantibodies Using HLA and Non-HLA Antigens
CN110268247B (zh) * 2017-01-30 2022-07-08 生物辐射实验室股份有限公司 单分子水平的蛋白质-蛋白质相互作用的测量
KR20210035167A (ko) * 2018-06-11 2021-03-31 파운데이션 메디신 인코포레이티드 게놈 변경을 평가하기 위한 조성물 및 방법
WO2020023484A1 (en) * 2018-07-23 2020-01-30 Genomics Usa, Inc. Blood typing using dna
IL316576A (en) * 2019-02-12 2024-12-01 Pact Pharma Inc Preparations and methods for identifying antigen-specific T cells

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61148B1 (en) 1988-03-10 1994-10-05 Ici Plc Method of detecting nucleotide sequences
US6551784B2 (en) * 1989-06-07 2003-04-22 Affymetrix Inc Method of comparing nucleic acid sequences
CA2032331A1 (en) * 1990-01-22 1991-07-23 Annie L. Wu Method and kits for detecting human leukocyte antigen dna
JPH0690757A (ja) * 1991-08-23 1994-04-05 Kitasato Inst:The Hla−drタイピング用塩基配列群とそれを用いた hla−drタイピング法
US6125194A (en) * 1996-02-06 2000-09-26 Caelum Research Corporation Method and system for re-screening nodules in radiological images using multi-resolution processing, neural network, and image processing
US6449562B1 (en) * 1996-10-10 2002-09-10 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
US5948627A (en) * 1997-05-30 1999-09-07 One Lambda Immunobead flow cytometric detection of anti-HLA panel-reactive antibody
US6207379B1 (en) 1998-09-11 2001-03-27 One Lambda Method for amplification of DNA
US7450229B2 (en) * 1999-01-25 2008-11-11 Amnis Corporation Methods for analyzing inter-cellular phenomena
US20030082549A1 (en) * 2000-08-30 2003-05-01 Xiangjun Liu Method for determining alleles
WO2002057743A2 (en) * 2001-01-17 2002-07-25 Streamline Proteomics, Llc. Methods of analyzing and sorting one or more analytes
US20030165865A1 (en) * 2001-01-29 2003-09-04 Hinkel Christopher A. Methods of analysis of nucleic acids
WO2002090337A1 (en) * 2001-05-07 2002-11-14 Smithkline Beecham Corporation Sulfonamides
BR0212773A (pt) 2001-09-24 2004-10-13 One Lambda Métodos para detecção de sequências-alvo de ácido nucléico com marcadores diagnósticos
US7732138B2 (en) * 2001-11-07 2010-06-08 Diagcor Bioscience Incorporation Limited Rapid genotyping analysis and the device thereof
US7848889B2 (en) * 2004-08-02 2010-12-07 Bioarray Solutions, Ltd. Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
WO2006060872A1 (en) * 2004-12-10 2006-06-15 Genera Biosystems Pty Ltd Human papilloma virus (hpv) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (facs)
WO2006115870A2 (en) * 2005-04-20 2006-11-02 Becton Dickinson And Company Multiplex microparticle system
US7871770B2 (en) 2005-08-09 2011-01-18 Maxwell Sensors, Inc. Light transmitted assay beads
US20070238140A1 (en) * 2006-04-07 2007-10-11 Pentoney Stephen L Jr Method For Multiplex Bead-Based Assays Using Chemiluminescence and Fluorescence

Also Published As

Publication number Publication date
JP5684564B2 (ja) 2015-03-11
CN105112503B (zh) 2018-10-16
CA2686211A1 (en) 2008-11-13
AU2008247686A1 (en) 2008-11-13
AU2008247686B2 (en) 2012-08-30
US9556483B2 (en) 2017-01-31
US20140272976A1 (en) 2014-09-18
JP2013116106A (ja) 2013-06-13
CN101802217B (zh) 2015-08-19
US8748090B2 (en) 2014-06-10
EP2152908B1 (en) 2017-03-15
WO2008137530A1 (en) 2008-11-13
EP2152908A4 (en) 2010-07-28
US20090142762A1 (en) 2009-06-04
CA2686211C (en) 2018-08-21
CN105112503A (zh) 2015-12-02
JP2010526298A (ja) 2010-07-29
CN101802217A (zh) 2010-08-11
JP5755632B2 (ja) 2015-07-29
EP2152908A1 (en) 2010-02-17

Similar Documents

Publication Publication Date Title
NO2022027I1 (no) Combination of daunorubicin and cytarabine
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BRPI0813212A2 (pt) Métodos de tratamento de doenças e distúrbios mediados por serotonina
HRP20180572T1 (hr) 1' -supstituirani karba-nukleozidni analozi za antivirusnu terapiju
BRPI0719929A2 (pt) Partículas que compreendem um siloxano fluorado e métodos de preparo e uso das mesmas
BRPI0822064A2 (pt) Dispositivos de imageamento fotoacústico e métodos de imageamento
BRPI0818349A2 (pt) Dispositivo de reconstrução
BRPI0922122A2 (pt) composições e métodos para tratamento de doença celíaca.
BRPI0920891A2 (pt) misturas de alfa-amilase e métodos para uso das referidas misturas
BRPI0716439A2 (pt) formulaÇÕes de flibanserina e mÉtodo para fabricaÇço das mesmas.
BRPI0911297A2 (pt) composição e métodos para preparo e uso das mesmas
BRPI0820556A2 (pt) Bactéria e métodos para uso das mesmas
BRPI0818056A2 (pt) Aparelho e métodos para hemodiálise
EP2217371A4 (en) CATALYSTS AND RELATED METHODS
PT2868315T (pt) Formulações melhoradas e métodos para liofilização e liofilizados assim produzidos
BRPI0910763A2 (pt) métodos e dispositivos para dissecção de tecidos
FI20060449L (fi) Mammografiamenetelmä ja mammografialaite
BRPI0912290A2 (pt) detergentes para pele e mãos.
BRPI0716592A2 (pt) Composição para cuidado da pele
CY2016053I1 (el) Μεθοδοι αγωγης χρησιμοποιωντας φαρμακευτικες ουσιες συλληψης αμμωνιας
BRPI0822349A2 (pt) composições e métodos para tratar doenças lisossômicas
ATE494839T1 (de) Gewebeentnahme
BRPI0814876A2 (pt) Análogos de pirona fosforilados e métodos
BRPI0919794A2 (pt) dispositivo para uso intracorpóreo, e, composto
BRPI0814645A2 (pt) Métodos e composições para tratar de doença autoimune.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]